{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:26:37Z","timestamp":1790627197804,"version":"4.1.0"},"reference-count":151,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.phrs.2018.02.030","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T19:13:31Z","timestamp":1519758811000},"page":"308-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Dosing ribavirin in hepatitis E-infected solid organ transplant recipients"],"prefix":"10.1016","volume":"130","author":[{"given":"Brenda C.M.","family":"De Winter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis A.","family":"Hesselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1930-8964","authenticated-orcid":false,"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000149370","article-title":"Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route","volume":"20","author":"Balayan","year":"1983","journal-title":"Intervirology"},{"issue":"9","key":"10.1016\/j.phrs.2018.02.030_bib0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cmi.2017.02.026","article-title":"The added value of hepatitis E diagnostics in determining causes of hepatitis in routine diagnostic settings in the Netherlands","volume":"23","author":"Doting","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0015","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1128\/CMR.00057-13","article-title":"Hepatitis E virus infection","volume":"27","author":"Kamar","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.phrs.2018.02.030_bib0020","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0025","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/liv.13037","article-title":"Extrahepatic manifestations of hepatitis E virus","volume":"36","author":"Kamar","year":"2016","journal-title":"Liver Int."},{"issue":"12","key":"10.1016\/j.phrs.2018.02.030_bib0030","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMoa1215246","article-title":"Ribavirin for chronic hepatitis E virus infection in transplant recipients","volume":"370","author":"Kamar","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2018.02.030_bib0035","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1440-1746.2010.06540.x","article-title":"Hepatitis E: Historical, contemporary and future perspectives","volume":"26","author":"Aggarwal","year":"2011","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0040","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.virusres.2007.02.002","article-title":"Genetic variability and evolution of hepatitis E virus","volume":"127","author":"Okamoto","year":"2007","journal-title":"Virus Res."},{"issue":"Suppl. 45","key":"10.1016\/j.phrs.2018.02.030_bib0045","first-page":"1","article-title":"Epidemiology","author":"Viswanathan","year":"1957","journal-title":"Indian J. Med. Res."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0050","first-page":"597","article-title":"A large waterborne viral hepatitis E epidemic in Kanpur, India","volume":"70","author":"Naik","year":"1992","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.phrs.2018.02.030_bib0055","doi-asserted-by":"crossref","first-page":"17086","DOI":"10.1038\/nrdp.2017.86","article-title":"Hepatitis E virus infection","volume":"3","author":"Kamar","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"8199","key":"10.1016\/j.phrs.2018.02.030_bib0060","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(80)90205-6","article-title":"Chronic liver disease after non-A, non-B hepatitis","volume":"2","author":"Khuroo","year":"1980","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.phrs.2018.02.030_bib0065","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1086\/651077","article-title":"Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda","volume":"50","author":"Teshale","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2018.02.030_bib0070","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1440-1746.2004.03437.x","article-title":"Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area","volume":"19","author":"Khuroo","year":"2004","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1423-0410.2000.7920072.x","article-title":"Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E","volume":"79","author":"Arankalle","year":"2000","journal-title":"Vox Sang."},{"issue":"8956","key":"10.1016\/j.phrs.2018.02.030_bib0080","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(95)90761-0","article-title":"Vertical transmission of hepatitis E virus","volume":"345","author":"Khuroo","year":"1995","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.phrs.2018.02.030_bib0085","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2893.2009.01101.x","article-title":"Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers","volume":"16","author":"Khuroo","year":"2009","journal-title":"J. Viral Hepat."},{"issue":"11","key":"10.1016\/j.phrs.2018.02.030_bib0090","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.ebiom.2015.09.030","article-title":"A nationwide survey of hepatitis E virus infection and chronic hepatitis E in liver transplant recipients in Japan","volume":"2","author":"Inagaki","year":"2015","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0095","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/vox.12425","article-title":"Hepatitis E virus in donor plasma collected in Japan","volume":"111","author":"Minagi","year":"2016","journal-title":"Vox Sang."},{"issue":"9","key":"10.1016\/j.phrs.2018.02.030_bib0100","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3201\/eid1909.130013","article-title":"Hepatitis E virus genotype 4, Nanjing, China, 2001\u20132011","volume":"19","author":"Dai","year":"2013","journal-title":"Emerg. Infect. Dis."},{"issue":"8","key":"10.1016\/j.phrs.2018.02.030_bib0105","doi-asserted-by":"crossref","DOI":"10.3390\/v8080211","article-title":"Hepatitis E seroprevalence in Europe: a meta-analysis","volume":"8","author":"Hartl","year":"2016","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/trf.13402","article-title":"Incidence and duration of hepatitis E virus infection in Dutch blood donors","volume":"56","author":"Hogema","year":"2016","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.phrs.2018.02.030_bib0115","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.3201\/eid1712.110371","article-title":"Hepatitis E virus antibody in blood donors, France","volume":"17","author":"Mansuy","year":"2011","journal-title":"Emerg. Infect. Dis."},{"issue":"9","key":"10.1016\/j.phrs.2018.02.030_bib0120","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.3201\/eid2309.170081","article-title":"Estimated annual numbers of foodborne pathogen-associated illnesses, hospitalizations, and deaths, France, 2008\u20132013","volume":"23","author":"Van Cauteren","year":"2017","journal-title":"Emerg. Infect. Dis."},{"issue":"9956","key":"10.1016\/j.phrs.2018.02.030_bib0125","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0130","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.3201\/eid1810.111756","article-title":"Hepatitis E virus seroprevalence among adults, Germany","volume":"18","author":"Faber","year":"2012","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1086\/599319","article-title":"Epidemiology of hepatitis E virus in the United States: results from the third national health and nutrition examination survey, 1988\u20131994","volume":"200","author":"Kuniholm","year":"2009","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0140","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/hep.27219","article-title":"Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey","volume":"60","author":"Ditah","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"12","key":"10.1016\/j.phrs.2018.02.030_bib0145","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1586\/eri.11.138","article-title":"The epidemiology of hepatitis E virus infections in developed countries and among immunocompromised patients","volume":"9","author":"Nelson","year":"2011","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0150","doi-asserted-by":"crossref","DOI":"10.3390\/v8100270","article-title":"Zoonotic hepatitis E virus: classification, animal reservoirs and transmission routes","volume":"8","author":"Doceul","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.phrs.2018.02.030_bib0155","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13567-014-0121-8","article-title":"Natural and experimental hepatitis E virus genotype 3-infection in European wild boar is transmissible to domestic pigs","volume":"45","author":"Schlosser","year":"2014","journal-title":"Vet. Res."},{"issue":"8","key":"10.1016\/j.phrs.2018.02.030_bib0160","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3201\/eid1808.120057","article-title":"Hepatitis E virus strains in rabbits and evidence of a closely related strain in humans, france","volume":"18","author":"Izopet","year":"2012","journal-title":"Emerg. Infect. Dis."},{"issue":"17","key":"10.1016\/j.phrs.2018.02.030_bib0165","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1128\/AEM.00336-10","article-title":"Molecular detection of hepatitis E virus in sewage samples","volume":"76","author":"La Rosa","year":"2010","journal-title":"Appl. Environ. Microbiol."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/j.gastro.2015.10.048","article-title":"Chronic infection with camelid hepatitis E virus in a liver transplant recipient who regularly consumes camel meat and milk","volume":"150","author":"Lee","year":"2016","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0175","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/hep.28436","article-title":"A nationwide survey of hepatitis E viral infection in French blood donors","volume":"63","author":"Mansuy","year":"2016","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0180","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/655898","article-title":"Pig liver sausage as a source of hepatitis E virus transmission to humans","volume":"202","author":"Colson","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"11","key":"10.1016\/j.phrs.2018.02.030_bib0185","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3201\/eid2011.140791","article-title":"Foodborne transmission of hepatitis E virus from raw pork liver sausage, France","volume":"20","author":"Renou","year":"2014","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0190","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MCG.0000000000000113","article-title":"Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion","volume":"49","author":"Riveiro-Barciela","year":"2015","journal-title":"J. Clin. Gastroenterol."},{"issue":"14","key":"10.1016\/j.phrs.2018.02.030_bib0195","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1128\/AEM.00978-14","article-title":"Bioaccumulation efficiency, tissue distribution, and environmental occurrence of hepatitis E virus in bivalve shellfish from France","volume":"80","author":"Grodzki","year":"2014","journal-title":"Appl. Environ. Microbiol."},{"issue":"12","key":"10.1016\/j.phrs.2018.02.030_bib0200","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3201\/eid1812.120924","article-title":"Hepatitis E virus genotype 3 in shellfish, United Kingdom","volume":"18","author":"Crossan","year":"2012","journal-title":"Emerg. Infect. Dis."},{"issue":"7","key":"10.1016\/j.phrs.2018.02.030_bib0205","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3201\/eid2307.170318","article-title":"Rabbit hepatitis E virus infections in humans, France","volume":"23","author":"Abravanel","year":"2017","journal-title":"Emerg. Infect. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0210","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/trf.13937","article-title":"Prevalence of hepatitis E virus infection among blood donors in mainland China: a meta-analysis","volume":"57","author":"Zhang","year":"2017","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0215","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/trf.13994","article-title":"Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression","volume":"57","author":"Satake","year":"2017","journal-title":"Transfusion"},{"issue":"Dec. (12)","key":"10.1016\/j.phrs.2018.02.030_bib0220","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1111\/trf.14285","article-title":"Low hepatitis E virus RNA prevalence in a large-scale survey of United States source plasma donors","volume":"57","author":"Roth","year":"2017","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0225","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/trf.13978","article-title":"Cost-effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands","volume":"57","author":"de Vos","year":"2017","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0230","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/hep.27244","article-title":"Decline in hepatitis E virus antibody prevalence in southeastern Germany, 1996\u20132011","volume":"60","author":"Wenzel","year":"2014","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/nrgastro.2010.207","article-title":"Hepatitis: hepatitis E vaccination\u2013is HEV 239 the breakthrough?","volume":"8","author":"Wedemeyer","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0240","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/hep.25505","article-title":"The global burden of hepatitis E virus genotypes 1 and 2 in 2005","volume":"55","author":"Rein","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0245","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.24738","article-title":"Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection","volume":"55","author":"Suneetha","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0250","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jinf.2016.02.016","article-title":"Conventional and innate lymphocytes response at the acute phase of HEV infection in transplanted patients","volume":"72","author":"Abravanel","year":"2016","journal-title":"J. Infect."},{"issue":"9235","key":"10.1016\/j.phrs.2018.02.030_bib0255","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0140-6736(00)02737-9","article-title":"Duration of viraemia and faecal viral excretion in acute hepatitis E","volume":"356","author":"Aggarwal","year":"2000","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.phrs.2018.02.030_bib0260","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa0706992","article-title":"Hepatitis E virus and chronic hepatitis in organ-transplant recipients","volume":"358","author":"Kamar","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0265","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1086\/655899","article-title":"Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France","volume":"202","author":"Legrand-Abravanel","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"9835","key":"10.1016\/j.phrs.2018.02.030_bib0270","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/S0140-6736(11)61849-7","article-title":"Hepatitis E","volume":"379","author":"Kamar","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0275","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2016.11.016","article-title":"Hepatitis E virus: infection beyond the liver?","volume":"66","author":"Pischke","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phrs.2018.02.030_bib0280","first-page":"2014","article-title":"Hepatitis E-associated encephalopathy in a renal transplant recipient","author":"de Vries","year":"2014","journal-title":"BMJ Case Rep."},{"issue":"9","key":"10.1016\/j.phrs.2018.02.030_bib0285","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1128\/JCM.39.9.3040-3046.2001","article-title":"Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model","volume":"39","author":"Williams","year":"2001","journal-title":"J. Clin. Microbiol."},{"issue":"Pt 6","key":"10.1016\/j.phrs.2018.02.030_bib0290","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1099\/vir.0.063602-0","article-title":"Evidence of extrahepatic replication of hepatitis E virus in human placenta","volume":"95","author":"Bose","year":"2014","journal-title":"J. Gen. Virol."},{"issue":"July (7)","key":"10.1016\/j.phrs.2018.02.030_bib0295","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/jvh.12515","article-title":"Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells","volume":"23","author":"Drave","year":"2016","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0300","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jhep.2015.08.034","article-title":"Detection and assessment of infectivity of hepatitis E virus in urine","volume":"64","author":"Geng","year":"2016","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0305","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/apt.13309","article-title":"Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK\/French study","volume":"42","author":"Blasco-Perrin","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0310","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2893.2007.00858.x","article-title":"Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy","volume":"14","author":"Peron","year":"2007","journal-title":"J. Viral Hepat."},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0315","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.cgh.2015.04.014","article-title":"Hepatitis E virus infection as a possible cause of acute liver failure in europe","volume":"13","author":"Manka","year":"2015","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0320","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clinre.2013.05.013","article-title":"Liver transplantation for acute liver failure related to autochthonous genotype 3 hepatitis E virus infection","volume":"38","author":"Aherfi","year":"2014","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0325","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jceh.2013.08.013","article-title":"Hepatitis E and acute-on-chronic liver failure","volume":"3","author":"Kumar","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.phrs.2018.02.030_bib0330","article-title":"Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland","author":"Fraga","year":"2017","journal-title":"Liver Int."},{"issue":"Suppl. 45","key":"10.1016\/j.phrs.2018.02.030_bib0335","first-page":"71","article-title":"Infectious hepatitis in pregnancy during Delhi epidemic","author":"Naidu","year":"1957","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0340","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jcv.2012.01.016","article-title":"First case report of an acute genotype 3 hepatitis E infected pregnant woman living in South-Eastern France","volume":"54","author":"Anty","year":"2012","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.phrs.2018.02.030_bib0345","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1743-422X-11-68","article-title":"Prospective study of hepatitis E virus infection among pregnant women in France","volume":"11","author":"Renou","year":"2014","journal-title":"Virol. J."},{"issue":"11","key":"10.1016\/j.phrs.2018.02.030_bib0350","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3201\/eid1511.091094","article-title":"Hepatitis E outbreak on cruise ship","volume":"15","author":"Said","year":"2009","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0355","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/cid\/civ862","article-title":"High proportion of asymptomatic infections in an outbreak of hepatitis E associated with a spit-roasted piglet, France, 2013","volume":"62","author":"Guillois","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0360","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2011.02.050","article-title":"Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants","volume":"140","author":"Kamar","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2018.02.030_bib0365","first-page":"20","article-title":"Hepatitis E virus detection in liver tissue from patients with suspected drug-induced liver injury","volume":"2","author":"Chijioke","year":"2015","journal-title":"Front. Med. (Lausanne)"},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0370","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1365-2036.2007.03504.x","article-title":"The role of hepatitis E virus testing in drug-induced liver injury","volume":"26","author":"Dalton","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0375","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1053\/j.gastro.2011.07.051","article-title":"Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury","volume":"141","author":"Davern","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2018.02.030_bib0380","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMc0708687","article-title":"Chronic hepatitis E with cirrhosis in a kidney-transplant recipient","volume":"358","author":"Gerolami","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.phrs.2018.02.030_bib0385","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1399-3046.2012.01740.x","article-title":"Prevalence of hepatitis E virus infection in pediatric solid organ transplant recipients\u2013a single-center experience","volume":"16","author":"Hoerning","year":"2012","journal-title":"Pediatr. Transplant."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0390","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/bmt.2013.148","article-title":"Hepatitis E virus infection in a hematopoietic stem cell donor","volume":"49","author":"Koenecke","year":"2014","journal-title":"Bone Marrow Transplant."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0395","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jcv.2010.06.016","article-title":"Hepatitis E virus excretion can be prolonged in patients with hematological malignancies","volume":"49","author":"Tavitian","year":"2010","journal-title":"J. Clin. Virol."},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0400","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJMc0903778","article-title":"Persistent carriage of hepatitis E virus in patients with HIV infection","volume":"361","author":"Dalton","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0405","doi-asserted-by":"crossref","first-page":"430","DOI":"10.7326\/0003-4819-150-6-200903170-00026","article-title":"Chronic hepatitis after hepatitis E virus infection in a patient with non-hodgkin lymphoma taking rituximab","volume":"150","author":"Ollier","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"14","key":"10.1016\/j.phrs.2018.02.030_bib0410","doi-asserted-by":"crossref","first-page":"e675","DOI":"10.1097\/MD.0000000000000675","article-title":"Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study","volume":"94","author":"Bauer","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0415","first-page":"e15618","article-title":"Persistent hepatitis E virus genotype 4 infection in a child with acute lymphoblastic leukemia","volume":"14","author":"Geng","year":"2014","journal-title":"Hepat. Mon."},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0420","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1111\/jvh.12027","article-title":"Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area","volume":"20","author":"Naik","year":"2013","journal-title":"J. Viral Hepat."},{"issue":"7","key":"10.1016\/j.phrs.2018.02.030_bib0425","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/ajt.12253","article-title":"How should hepatitis E virus infection be defined in organ-transplant recipients?","volume":"13","author":"Kamar","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0430","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/TP.0b013e3181c4096c","article-title":"Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation","volume":"89","author":"Kamar","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2018.02.030_bib0435","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jcv.2015.11.038","article-title":"Hepatitis E virus genotype 3 infection in a tertiary referral center in the Netherlands: clinical relevance and impact on patient morbidity","volume":"74","author":"Nijskens","year":"2016","journal-title":"J. Clin. Virol."},{"issue":"8","key":"10.1016\/j.phrs.2018.02.030_bib0440","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1600-6143.2008.02286.x","article-title":"Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients","volume":"8","author":"Kamar","year":"2008","journal-title":"Am. J. Transplant."},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0445","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/lt.21480","article-title":"Chronic hepatitis E virus infection in liver transplant recipients","volume":"14","author":"Haagsma","year":"2008","journal-title":"Liver Transpl."},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0450","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/hep.24738","article-title":"HEV-specific T- cell responses are associated with control of HEV infection","volume":"55","author":"Suneetha","year":"2012","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"27","key":"10.1016\/j.phrs.2018.02.030_bib0455","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1073\/pnas.1705446114","article-title":"Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity","volume":"114","author":"Cao","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.phrs.2018.02.030_bib0460","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1053\/j.gastro.2014.02.036","article-title":"Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus","volume":"146","author":"Wang","year":"2014","journal-title":"Gastroenterology"},{"issue":"Oct. (4)","key":"10.1016\/j.phrs.2018.02.030_bib0465","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jhep.2014.05.026","article-title":"Rapamycin and everolimus facilitate hepatitis E virus replication: revealing a basal defense mechanism of PI3K-PKB-mTOR pathway","volume":"61","author":"Zhou","year":"2014","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0470","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrneurol.2015.234","article-title":"Hepatitis E virus and neurological injury","volume":"12","author":"Dalton","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0475","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3201\/eid1702.100856","article-title":"Hepatitis E virus and neurologic disorders","volume":"17","author":"Kamar","year":"2011","journal-title":"Emerg. Infect. Dis."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0480","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1212\/WNL.0000000000000111","article-title":"Guillain-Barre syndrome associated with preceding hepatitis E virus infection","volume":"82","author":"van den Berg","year":"2014","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.phrs.2018.02.030_bib0485","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1093\/cid\/cit512","article-title":"Hepatitis E and Guillain-Barre syndrome","volume":"57","author":"Geurtsvankessel","year":"2013","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.phrs.2018.02.030_bib0490","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s10072-016-2644-4","article-title":"Guillain-Barre and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan","volume":"37","author":"Fukae","year":"2016","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0495","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/jamaneurol.2016.3541","article-title":"Diagnostic challenges and clinical characteristics of hepatitis E virus-associated Guillain-Barre syndrome","volume":"74","author":"Stevens","year":"2017","journal-title":"JAMA Neurol."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0500","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.0000000000000112","article-title":"Neuralgic amyotrophy and hepatitis E virus infection","volume":"82","author":"van Eijk","year":"2014","journal-title":"Neurology"},{"issue":"Nov. (5)","key":"10.1016\/j.phrs.2018.02.030_bib0505","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jhep.2017.07.010","article-title":"Hepatitis E infection and acute non-traumatic neurological injury: a prospective pilot multicenter study","volume":"67","author":"Dalton","year":"2017","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0510","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/TP.0b013e318245f14c","article-title":"Hepatitis E virus and the kidney in solid-organ-transplant patients","volume":"93","author":"Kamar","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2018.02.030_bib0515","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/0971-4065.34822","article-title":"Heptitis E associated immune thrombocytopenia and membranous glomerulonephritis","volume":"11","author":"Ali","year":"2001","journal-title":"Indian J. Nephrol."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0520","doi-asserted-by":"crossref","first-page":"E211","DOI":"10.1111\/tid.12143","article-title":"Hepatitis E virus infection as a new probable cause of de novo membranous nephropathy after kidney transplantation","volume":"15","author":"Taton","year":"2013","journal-title":"Transpl. Infect. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0525","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.ajkd.2015.10.022","article-title":"Hepatitis E virus-induced cryglobulinemic glomerulonephritis in a non-immunocompromised person","volume":"67","author":"Guinault","year":"2016","journal-title":"Am. J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0530","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/tid.12353","article-title":"Successful treatment of hepatitis E virus-associated cryoglobulinemic membranoproliferative glomerulonephritis with ribavirin","volume":"17","author":"Del Bello","year":"2015","journal-title":"Transpl. Infect. Dis."},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0535","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/liv.12911","article-title":"Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study","volume":"36","author":"Peron","year":"2016","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0540","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jcv.2011.06.004","article-title":"Treatment of severe acute hepatitis E by ribavirin","volume":"52","author":"Gerolami","year":"2011","journal-title":"J. Clin. Virol."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0545","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0550","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.3851\/IMP2317","article-title":"Ribavirin therapy for hepatitis E virus-induced acute on chronic liver failure: a preliminary report","volume":"17","author":"Goyal","year":"2012","journal-title":"Antivir. Ther."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0555","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1086\/650488","article-title":"Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation","volume":"50","author":"Kamar","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0560","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/lt.22014","article-title":"Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b","volume":"16","author":"Haagsma","year":"2010","journal-title":"Liver Transpl."},{"issue":"8","key":"10.1016\/j.phrs.2018.02.030_bib0565","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/ndt\/gfq282","article-title":"Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient","volume":"25","author":"Kamar","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0570","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","article-title":"Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients","volume":"59","author":"Rostaing","year":"1995","journal-title":"Transplantation"},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0575","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-153-2-201007200-00257","article-title":"Brief communication: case reports of ribavirin treatment for chronic hepatitis E","volume":"153","author":"Mallet","year":"2010","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0580","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","article-title":"Ribavirin therapy inhibits viral replication in patients with chronic hepatitis E virus infection","volume":"139","author":"Kamar","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0585","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/cid\/ciu742","article-title":"Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse","volume":"60","author":"Abravanel","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0590","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/AAC.01795-13","article-title":"Ribavirin inhibits in vitro hepatitis E virus replication through depletion of cellular GTP pools and is moderately synergistic with alpha interferon","volume":"58","author":"Debing","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0595","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/hep.25562","article-title":"Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C virus infection in vitro and in vivo","volume":"55","author":"Pan","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0600","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.antiviral.2006.10.003","article-title":"Ribavirin and mycophenolic acid markedly potentiate the anti-hepatitis B virus activity of entecavir","volume":"73","author":"Ying","year":"2007","journal-title":"Antiviral Res."},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0605","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1097\/TP.0000000000000850","article-title":"An early viral response predicts the virological response to ribavirin in hepatitis E virus organ transplant patients","volume":"99","author":"Kamar","year":"2015","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0610","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1478-3231.2008.01896.x","article-title":"Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms","volume":"28","author":"Hofmann","year":"2008","journal-title":"Liver Int."},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0615","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/gutjnl-2016-312040","article-title":"Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing","volume":"65","author":"Gouttenoire","year":"2016","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0620","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1136\/gutjnl-2015-311000","article-title":"In vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome","volume":"65","author":"Todt","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0625","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1128\/AAC.02496-15","article-title":"Mutation in the hepatitis E virus polymerase and outcome of ribavirin therapy","volume":"60","author":"Lhomme","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.phrs.2018.02.030_bib0630","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2016.05.002","article-title":"Hepatitis E virus mutations associated with ribavirin treatment failure result in altered viral fitness and ribavirin sensitivity","volume":"65","author":"Debing","year":"2016","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.phrs.2018.02.030_bib0635","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/jvh.12403","article-title":"Antiviral therapy in chronic hepatitis E: a systematic review","volume":"22","author":"Peters van Ton","year":"2015","journal-title":"J. Viral Hepat."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0640","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1053\/j.gastro.2010.08.002","article-title":"Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection","volume":"139","author":"Kamar","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0645","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0973-6883(12)60090-5","article-title":"A pharmacological profile of ribavirin and monitoring of its plasma concentration in chronic hepatitis C infection","volume":"2","author":"Naik","year":"2012","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.phrs.2018.02.030_bib0650","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12967-015-0682-y","article-title":"Relationship between ITPA polymorphisms and hemolytic anemia in HCV-infected patients after ribavirin-based therapy: a meta-analysis","volume":"13","author":"Pineda-Tenor","year":"2015","journal-title":"J. Transl. Med."},{"issue":"2\u20133","key":"10.1016\/j.phrs.2018.02.030_bib0655","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000081741","article-title":"Significance of serum ribavirin concentration in combination therapy of interferon and ribavirin for chronic hepatitis C","volume":"48","author":"Arase","year":"2005","journal-title":"Intervirology"},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0660","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00007691-200402000-00004","article-title":"Dosage adjustment of ribavirin based on renal function in Japanese patients with chronic hepatitis C","volume":"26","author":"Maeda","year":"2004","journal-title":"Ther. Drug Monit."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0665","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/hep.20563","article-title":"High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis C","volume":"41","author":"Lindahl","year":"2005","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.phrs.2018.02.030_bib0670","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/bdra.20682","article-title":"The ribavirin pregnancy registry: findings after 5 years of enrollment, 2003\u20132009","volume":"88","author":"Roberts","year":"2010","journal-title":"Birth Defects Res. A Clin. Mol. Teratol."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0675","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/jac\/dkn421","article-title":"Usefulness of monitoring ribavirin plasma concentrations to improve treatment response in patients with chronic hepatitis C","volume":"62","author":"Morello","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"issue":"10","key":"10.1016\/j.phrs.2018.02.030_bib0680","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1128\/AAC.43.10.2451","article-title":"Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology","volume":"43","author":"Preston","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2018.02.030_bib0685","first-page":"17","article-title":"The clinical pharmacology of ribavirin","volume":"19","author":"Glue","year":"1999","journal-title":"Semin. Liver Dis."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0690","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1023\/A:1011945103455","article-title":"Intestinal absorption of ribavirin is preferentially mediated by the Na+-nucleoside purine (N1) transporter","volume":"15","author":"Patil","year":"1998","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0695","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/he.2000.5789","article-title":"Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: role of membrane oxidative damage","volume":"31","author":"De Franceschi","year":"2000","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0700","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1128\/AAC.04618-14","article-title":"Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection","volume":"59","author":"Wu","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0705","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00007691-200212000-00004","article-title":"Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysis","volume":"24","author":"Bruchfeld","year":"2002","journal-title":"Ther. Drug Monit."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0710","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.ajkd.2003.09.019","article-title":"Ribavirin pharmacokinetics in renal and liver transplant patients: evidence that it depends on renal function","volume":"43","author":"Kamar","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0715","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/FTD.0b013e31828a9fbf","article-title":"Measuring ribavirin concentrations during the earliest stages of antiviral therapy for hepatitis C: potential relevance for treatment outcome","volume":"35","author":"van Vlerken","year":"2013","journal-title":"Ther. Drug Monit."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0720","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hep.22217","article-title":"Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C","volume":"47","author":"Loustaud-Ratti","year":"2008","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.phrs.2018.02.030_bib0725","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/QCO.0000000000000316","article-title":"Treatment of hepatitis E virus","volume":"29","author":"Dalton","year":"2016","journal-title":"Curr. Opin. Infect. Dis."},{"issue":"12","key":"10.1016\/j.phrs.2018.02.030_bib0730","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1128\/AAC.00608-13","article-title":"Safety, tolerability, and pharmacokinetics of ribavirin in hepatitis C virus-infected patients with various degrees of renal impairment","volume":"57","author":"Brennan","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.phrs.2018.02.030_bib0735","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.healun.2012.10.008","article-title":"Clinical implications of chronic hepatitis E virus infection in heart transplant recipients","volume":"32","author":"Koning","year":"2013","journal-title":"J. Heart Lung Transplant."},{"issue":"2","key":"10.1016\/j.phrs.2018.02.030_bib0740","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/tid.12183","article-title":"Course and treatment of chronic hepatitis E virus infection in lung transplant recipients","volume":"16","author":"Pischke","year":"2014","journal-title":"Transpl. Infect. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0745","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2014.08.040","article-title":"A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients","volume":"147","author":"Debing","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.phrs.2018.02.030_bib0750","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/tid.12411","article-title":"Relevance of chronic hepatitis E in liver transplant recipients: a real-life setting","volume":"17","author":"Galante","year":"2015","journal-title":"Transpl. Infect. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2018.02.030_bib0755","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/liv.12114","article-title":"Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience","volume":"33","author":"Pischke","year":"2013","journal-title":"Liver Int."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817315104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817315104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T02:01:04Z","timestamp":1751421664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817315104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":151,"alternative-id":["S1043661817315104"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.02.030","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosing ribavirin in hepatitis E-infected solid organ transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.02.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}